A few years ago, a women's health company could launch without a mental health component and nobody would question it. A menopause platform could focus on hot flashes and HRT without addressing the anxiety, depression, and cognitive changes that accompany perimenopause. A maternal health company could offer lactation support without screening for postpartum mood disorders. Mental health was adjacent - important, but optional.
That's no longer the case. Looking across the past year of coverage, what stands out is not just how much activity there is in women's mental health - but how many different ways it's entering the ecosystem. The numbers make the urgency clear: Women are twice as likely as men to experience depression and anxiety. Nearly 60% of women with perinatal mental health conditions never receive a diagnosis. Up to 70% of perimenopausal women experience mental health symptoms. And untreated perinatal conditions alone cost the U.S. healthcare system $14 billion annually, increasing the risk of preterm birth by 50%.
When the prevalence is this high and the consequences this measurable, mental health stops being an add-on. It starts becoming infrastructure. And the industry is responding - through at least four distinct models.
How Mental Health Is Entering Women's Health
Built in-house. Some companies are building mental health into their model from the start. Tia integrates therapy alongside primary care and gynecology as part of its whole-person clinic model - not as a referral destination, but as part of the core clinical experience. This approach treats mental health as inseparable from the rest of women's healthcare, but requires significant clinical infrastructure to deliver.
Standalone. A growing number of companies are being built specifically around women's mental health. Seven Starling raised $8 million for perinatal mental health, now operating across 18 states with 1,500 OBGYN partnerships and 90% of patients showing significant improvement. FamilyWell Health raised $8 million to embed virtual mental health services into OB-GYN practices, then expanded into perimenopause and menopause. Mamaya Health raised $3 million and expanded from maternal mental health into care for entire families. What's notable is that even as standalone companies, many of these operate through clinical partnerships and EMR integrations rather than as separate destinations - they're standalone in structure but embedded in delivery.
Partnered. Some companies are adding mental health through strategic partnerships rather than building or buying it. GenoPalate and Mamaya Health partnered to create cross-referral pathways between personalized nutrition and therapy - recognizing that for women navigating perimenopause or postpartum recovery, mental health and metabolic health are deeply intertwined. Care.com partnered with Headspace to address the mental health toll of caregiving, where 90% of parents report lost sleep and 89% report burnout. These partnerships signal that companies outside traditional women's health are recognizing the mental health dimension of the problems they're already serving.
Acquired. And then there are the acquisitions - two in a single week. Aeroflow Health acquired Canopie, adding maternal mental health to a platform that already connects 1.7 million mothers with lactation supplies and perinatal education. And WPS, a U.S. health insurer, acquired Mavida Health, a platform founded by a reproductive psychiatrist, specializing in mental health for women navigating reproductive life transitions. The Aeroflow deal is a care company filling a gap. The WPS deal is something different - a payer deciding this is a capability worth owning, not just reimbursing.
What This Signals
The fact that mental health is arriving through so many vectors at once - in-house, standalone, partnered, acquired - says something about where the industry is. This isn't one company's strategy. It's a category-wide recognition that women's mental health cannot be separated from the rest of women's healthcare without leaving patients underserved.
The WPS acquisition is perhaps the most telling signal. When a payer acquires rather than reimburses, it suggests they see specialized women's mental health as something that reduces total cost of care. And the economics support it: Untreated perinatal conditions increase preterm birth risk by 50%, and the downstream costs of complications far exceed the cost of early intervention. If more payers arrive at the same conclusion, it could change the economics for every company building in this space.
While the delivery models are varied, the direction is clear. A women's health platform without a mental health layer is starting to feel incomplete - not as a matter of branding, but as a matter of clinical reality
